Australian Clinical Labs Ltd (AU:ACL) has released an update.
JPMorgan Chase & Co. and its affiliates, previously holding an 11.95% stake in Australian Clinical Labs Ltd, have decreased their voting power to 10.24% as of September 13, 2024. The adjustment in shareholding is due to a combination of securities lending as agent lender and the purchase and sales of securities by its subsidiaries. This change represents a shift in the substantial holder’s interest in the company.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
